Savara, Inc.
(NASDAQ : MSTX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
Loading MSTX News...
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc.
0.98%73.430.9%$725.96m
AMGNAmgen Inc.
0.74%180.501.1%$595.35m
CELGCelgene Corporation
1.44%136.941.1%$590.12m
REGNRegeneron Pharmaceuticals, Inc.
2.57%519.802.7%$543.97m
BIIBBiogen Inc.
0.73%284.011.2%$408.40m
VRTXVertex Pharmaceuticals Incorporated
-0.22%159.341.9%$369.32m
ALXNAlexion Pharmaceuticals, Inc.
1.73%129.501.9%$285.42m
CLVSClovis Oncology, Inc.
3.88%87.1018.0%$175.66m
INCYIncyte Corporation
1.99%133.052.6%$169.81m
TSROTESARO, Inc.
3.30%128.1114.7%$169.65m
ILMNIllumina, Inc.
-0.39%173.203.5%$159.21m
EXELExelixis, Inc.
1.87%27.256.5%$156.22m
BMRNBioMarin Pharmaceutical Inc.
0.65%87.804.4%$131.91m
KITEKite Pharma, Inc.
2.58%108.1516.1%$122.72m
BLUEBluebird Bio, Inc.
0.21%97.5019.3%$117.55m

Company Profile

Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, T.